AstraZeneca has recently completed a significant clinical study titled ‘A Multicenter, Single-arm, Open-label, Post-Authorization, Phase 4 Effectiveness and Safety Study of Tezepelumab in Adult and ...

Questions remain on whether there are links between patients with asthma and RA, including heterogeneity of disease.

The ultra-long acting investigational biologic is administered once every 6 months as a subcutaneous injection. Depemokimab reduced the rate of exacerbations in patients with severe asthma with type 2 ...

For many years, treatment of asthma has focused on symptom management and control. As the understanding of disease processes has improved and treatments begin to target underlying mechanisms, there is ...

GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has recently updated its clinical study ...

Patients with severe asthma receiving mepolizumab experience reductions in healthcare resource use and improvements in work ...

If you are wheezing, coughing, or having extreme shortness of breath, you may be having an asthma attack.

The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic inflammatory sinus ...

Blood eosinophil count and fractional exhaled nitric oxide (FeNO) play an important role in selecting biological therapies for severe asthma. This analysis of patient-level data pooled across 22 ...

Please provide your email address to receive an email when new articles are posted on . The questionnaire assessed general fatigue, sleep-rest fatigue and cognitive fatigue. Asthma-related quality of ...